NEUROENDOCRINE DIFFERENTIATION IN POORLY DIFFERENTIATED LUNG CARCINOMAS - A LIGHT MICROSCOPIC AND IMMUNOHISTOLOGIC STUDY

被引：0
|
作者：
VISSCHER, DW
ZARBO, RJ
TROJANOWSKI, JQ
SAKR, W
CRISSMAN, JD
机构：
[1] HARPER GRACE HOSP,DEPT PATHOL,DETROIT,MI 48201
[2] UNIV PENN,DEPT PATHOL,PHILADELPHIA,PA 19104
来源：
MODERN PATHOLOGY | 1990年 / 3卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：508 / 512
页数：5
相关论文
共 50 条
  • [21] Quantitative analysis of enhanced CT in differentiating well-differentiated pancreatic neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas
    Hai-Yan Chen
    Yao Pan
    Jie-Yu Chen
    Lu-lu Liu
    Yong-Bo Yang
    Kai Li
    Ri-Sheng Yu
    Guo-Liang Shao
    European Radiology, 2022, 32 : 8317 - 8325
  • [22] Quantitative analysis of enhanced CT in differentiating well-differentiated pancreatic neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas
    Chen, Hai-Yan
    Pan, Yao
    Chen, Jie-Yu
    Liu, Lu-lu
    Yang, Yong-Bo
    Li, Kai
    Yu, Ri-Sheng
    Shao, Guo-Liang
    EUROPEAN RADIOLOGY, 2022, 32 (12) : 8317 - 8325
  • [23] Therapeutic efficacy of platinum/etoposide regimens in the treatment of advanced poorly differentiated neuroendocrine carcinomas of the lung: A retrospective analysis
    Puliafito, Ivana
    Chillari, Federico
    Russo, Alessandro
    Cantale, Ornella
    Sciacca, Dorotea
    Castorina, Luigi
    Colarossi, Cristina
    Franchina, Tindara
    Vitale, Maria Paola
    Ricciardi, Giuseppina Rosaria Rita
    Adamo, Vincenzo
    Esposito, Francesca
    Giuffrida, Dario
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [24] Feasibility and Efficacy of Combined Cisplatin and Irinotecan Chemotherapy for Poorly Differentiated Neuroendocrine Carcinomas
    Nakano, Kenji
    Takahashi, Shunji
    Yuasa, Takeshi
    Nishimura, Noriko
    Mishima, Yuko
    Sakajiri, Sakura
    Yokoyama, Masahiro
    Tsuyama, Naoko
    Ishikawa, Yuichi
    Hatake, Kiyohiko
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 42 (08) : 697 - 703
  • [25] Achaete-scute-1 expression in poorly differentiated neuroendocrine carcinomas (NECs)
    La Rosa, S.
    Marando, A.
    Capella, C.
    VIRCHOWS ARCHIV, 2011, 459 : S24 - S24
  • [26] Comprehensive analysis of mutational and clinicopathologic characteristics of poorly differentiated colorectal neuroendocrine carcinomas
    Lee, Sun Mi
    Sung, Chang Ohk
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [27] Targeted Therapies Provide Treatment Options for Poorly Differentiated Pancreatic Neuroendocrine Carcinomas
    Gilabert, Marine
    Rho, Young Soo
    Kavan, Petr
    ONCOLOGY, 2017, 92 (03) : 170 - 172
  • [28] EXTRAPULMONARY POORLY DIFFERENTIATED NEUROENDOCRINE CARCINOMAS (PDNEC) TREATED WITH CISPLATIN PLUS IRINOTECAN
    de Celis Ferrari, Anezka Rubin
    Braghiroli, Maria Ignez
    Bariani, Giovanni Mendonca
    Munhoz, Rodrigo Ranella
    Pfiffer, Tulio Eduardo
    Hoff, Paulo Marcelo
    Riechelmann, Rachel Pimenta
    ANNALS OF ONCOLOGY, 2011, 22 : v80 - v80
  • [29] Comprehensive analysis of mutational and clinicopathologic characteristics of poorly differentiated colorectal neuroendocrine carcinomas
    Sun Mi Lee
    Chang Ohk Sung
    Scientific Reports, 11
  • [30] Concordance of genetic changes in colorectal poorly differentiated neuroendocrine carcinomas and associated adenocarcinomas
    Vortmeyer, AO
    Lubensky, IA
    Merino, MJ
    Wang, C
    Pham, T
    Furth, EE
    Zhuang, Z
    MODERN PATHOLOGY, 1998, 11 (01) : 72A - 72A
12345